000 01169 a2200325 4500
005 20250514060151.0
264 0 _c20030711
008 200307s 0 0 eng d
022 _a1568-0266
024 7 _a10.2174/1568026033392183
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCacciari, Barbara
245 0 0 _aMedicinal chemistry of A2A adenosine receptor antagonists.
_h[electronic resource]
260 _bCurrent topics in medicinal chemistry
_c2003
300 _a403-11 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aDrug Design
650 0 4 _aHeterocyclic Compounds
_xchemistry
650 0 4 _aHumans
650 0 4 _aNeurodegenerative Diseases
_xdrug therapy
650 0 4 _aPurinergic P1 Receptor Antagonists
650 0 4 _aReceptor, Adenosine A2A
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTriazoles
_xchemistry
650 0 4 _aXanthines
_xchemistry
700 1 _aPastorin, Giorgia
700 1 _aSpalluto, Giampiero
773 0 _tCurrent topics in medicinal chemistry
_gvol. 3
_gno. 4
_gp. 403-11
856 4 0 _uhttps://doi.org/10.2174/1568026033392183
_zAvailable from publisher's website
999 _c12368873
_d12368873